Market Sectors
Latest News
BACTEST Closes £900k Funding Round
Thursday, January 26 2012. UK based BACTEST Ltd. today announced that it had closed a £900k funding round led by the Low Carbon Innovation Fund (LCIF), managed by Turquoise International, which invested £300k in BACTEST.
Thursday, January 26 2012. UK based BACTEST Ltd. today announced that it had closed a £900k funding round led by the Low Carbon Innovation Fund (LCIF), managed by Turquoise International, which invested £300k in BACTEST.
Bactest creates new company for Health Sector
Bactest has created a wholly owned subsidiary to exploit its proprietory platform CYTOMAIA in the Human Health Sector. The new company GEMINI Diagnostics Ltd will focus on human clinical applications of CYTOMAIA.
Bactest has created a wholly owned subsidiary to exploit its proprietory platform CYTOMAIA in the Human Health Sector. The new company GEMINI Diagnostics Ltd will focus on human clinical applications of CYTOMAIA.
Water & Environmental
Environmental microbiology represents a rapidly growing market and one that affects people all across the globe.
The majority of Microbiology tests in this sector are associated with the production of drinking water and treatment of waste water.
The number of tests now exceeds 55 million per annnum with huge potential for efficiency improvements in Wastewater treatment through the application of biological monitoring of activated sludge processes.
CYTOMAIA has potential to be used in a range of applications in this market sector.
CYTOMAIA is important in the following situations:
- Where rapid contamination testing is important
- Where microbial matrices form part of the target process and monitoring of the metabolic activity is a useful measure of performance.
- Where accurate monitoring of microbial activity can be converted into enhanced process control through feedback loops to improve efficiency
- Where test technologies are driven by the factors of speed of test, cost of test, simplicity of test or required to be undertaken by relatively untrained staff.
- If “near process” testing and control, on-site will improve efficiency.
- Where monitoring of upstream additions to the wastewater and prevention of possible contamination of valuable microbial process beds by inhibitors (using metabolic activity as the measure) can reduce the potential for process failure and regeneration costs.
- Where a rapid result will facilitate corrective action or a recovery programme to protect and preserve process beds.
- Where improved efficiency results in reduced energy consumption, costs and carbon footprint.
Water quality affects every aspect of life, whether drinking water, waste water, surface water or bathing water.
Fundamental to the maintenance and control of water quality are surveillance systems and tests such as Microbial contamination, bioburden or waste water treatment efficiency.
Bactest offers benefits of rapid, automated testing suitable for use in the local environment.
Contact Us
